Govt to obtain clinical data from AstraZeneca

Science, Technology and Innovation Minister Khairy Jamaluddin says the government has a dual layer approach to advice on Covid-19 vaccines and would not make a decision based solely on media reports. – The Malaysian Insight file pic, April 2, 2021.

THE government will obtain the latest clinical data from Covid-19 vaccine manufacturer AstraZeneca, for analysis by the vaccine selection technical working group (TWG) and the National Pharmaceutical Regulatory Agency (NPRA), following news reports of side effects of the vaccine in the United Kingdom.

National Covid-19 Immunisation Programme co-ordinating minister Khairy Jamaluddin said that the government would not decide whether to proceed with the selection of the vaccine based just on news reports, but would look at clinical data.

Effective July 2018, access to full reports will only be available with a subscription. Sign-up now and enjoy one (1) week free access!

Subscribe Now!

Sign up or sign in here to comment.